ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



Dietary nucleotides supplementation enhances the growth and immune responses of the giant freshwater prawn, Macrobrachium rosenbergii (De Man, 1879)

Md. Belal Hossen, Md. Rokonuzzaman Kibria, Sakib Tahmid Rishan, Muhammad Tofazzal Hossain, Md. Samsul Alam.



Abstract
Download PDF Post

Objective: The study aimed to assess the impact of dietary nucleotide (NT) supplementation on the growth performance and immune response of juvenile Macrobrachium rosenbergii.
Materials and Methods: A commercial diet was supplemented with 0.0% (control), 0.10% (T1), 0.15% (T2), and 0.20% (T3) NT for the study. A total of 132 juvenile prawns (0.78 ± 0.03 gm) were randomly distributed into four groups, each having three replicates. Following the 75-day feeding trial, the experimental prawns were exposed to Aeromonas veronii at 8.35 × 105 colony forming unit (cfu)/ml for 7 days through a bath treatment.
Results: The growth parameters and survival rate were significantly higher (p < 0.05) in NT-supplemented prawns. Immune-related parameters, e.g., total hemocyte count (THC), hemolymph protein, albumin, globulin, superoxide dismutase, and catalase activity, were also significantly higher (p < 0.05) in NT-supplemented prawns. The challenge of prawn with A. veronii resulted in a significant reduction (p < 0.05) in THC and other biochemical parameters of hemolymph and caused mortality in all the experimental groups. However, significantly higher survival (p < 0.05) against the A. veronii challenge was found in NT-supplemented prawns. Conclusion: It can be concluded that dietary NTs should be supplemented at 0.15%–0.2% to enhance the growth, immunity, and resistance of juvenile M. rosenbergii against A. veronii.

Key words: Nucleotide; Macrobrachium rosenbergii; Growth; Hemolymph; Immunity; Aeromonas veronii.







Bibliomed Article Statistics

63
25
53
49
44
40
47
47
11
R
E
A
D
S

37

18

33

38

25

10

31

37

4
D
O
W
N
L
O
A
D
S
080910111201020304
20252026

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.